Corcept Therapeutics Inc
NASDAQ:CORT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Corcept Therapeutics Inc
NASDAQ:CORT
|
US |
|
Fox Factory Holding Corp
NASDAQ:FOXF
|
US |
|
OpGen Inc
NASDAQ:OPGN
|
US |
|
BCE Inc
TSX:BCE
|
CA |
|
Valley National Bancorp
NASDAQ:VLY
|
US |
|
Pembina Pipeline Corp
TSX:PPL
|
CA |
|
Evolution Mining Ltd
OTC:EVMNY
|
AU |
|
Japfa Comfeed Indonesia Tbk PT
IDX:JPFA
|
ID |
|
S
|
Shell PLC
AEX:SHELL
|
UK |
|
A
|
Abercrombie & Fitch Co
LSE:0R32
|
US |
|
Berlina Tbk PT
IDX:BRNA
|
ID |
|
D
|
Dis-Chem Pharmacies Ltd
JSE:DCP
|
ZA |
|
Qrf NV
XBRU:QRF
|
BE |
Wall St Price Targets
CORT Price Targets Summary
Corcept Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for CORT is 74.87 USD with a low forecast of 44.44 USD and a high forecast of 115.5 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CORT's stock price target?
Price Target
74.87
USD
According to Wall Street analysts, the average 1-year price target for CORT is 74.87 USD with a low forecast of 44.44 USD and a high forecast of 115.5 USD.
What is the Revenue forecast for Corcept Therapeutics Inc?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Revenue has been 52%. The projected CAGR for the next 8 years is 17%.
What is the Operating Income forecast for Corcept Therapeutics Inc?
Projected CAGR
58%
The compound annual growth rate for Operating Income over the next 8 years is 58%.
What is the Net Income forecast for Corcept Therapeutics Inc?
Projected CAGR
36%
The compound annual growth rate for Net Income over the next 8 years is 36%.
